eXoZymes, Inc. (EXOZ)

Market Cap	168.75M
Revenue (ttm)	-700
Net Income (ttm)	-5.12M
Shares Out	9.53M
EPS (ttm)	-0.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,427
Open	17.76
Previous Close	17.39
Day's Range	17.50 - 18.31
52-Week Range	8.50 - 23.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 4, 2025

About EXOZ

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. The company was founded in 2014 and is headquarter...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 29
• Stock Exchange: NASDAQ
• Ticker Symbol: EXOZ
• Website: https://www.invizyne.com

Financial Performance

In 2023, eXoZymes's revenue was $70,069, an increase of 145.01% compared to the previous year's $28,598. Losses were -$2.04 million, 46.0% more than in 2022.